Embecta (NASDAQ:EMBC) Shares Down 6.3% – What’s Next?

25 Jan 2026, 12:28 by Mitch Edgeman · The Markets Daily

Shares of Embecta Corp. (NASDAQ:EMBC – Get Free Report) dropped 6.3% during mid-day trading on Friday . The company traded as low as $11.34 and last traded at $11.32. Approximately 178,398 shares changed hands during trading, a decline of 62% from the average daily volume of 468,064 shares. The stock had previously closed at $12.08.

Analysts Set New Price Targets

Several analysts recently weighed in on EMBC shares. Zacks Research lowered Embecta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Embecta in a research report on Wednesday. Wall Street Zen upgraded shares of Embecta from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 27th. Finally, BTIG Research reiterated a “buy” rating on shares of Embecta in a report on Tuesday, November 25th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $18.50.

Get Our Latest Stock Analysis on EMBC

Embecta Price Performance

The stock has a market capitalization of $647.76 million, a P/E ratio of 6.71 and a beta of 1.11. The stock’s fifty day moving average price is $12.37 and its 200 day moving average price is $12.94.

Embecta (NASDAQ:EMBC – Get Free Report) last released its quarterly earnings data on Tuesday, November 25th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.04. The company had revenue of $263.30 million during the quarter, compared to analysts’ expectations of $265.66 million. Embecta had a net margin of 8.83% and a negative return on equity of 24.62%. The firm’s quarterly revenue was down 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.45 EPS. Embecta has set its FY 2026 guidance at 2.800-3.000 EPS. On average, sell-side analysts expect that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Friday, December 5th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Friday, December 5th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 5.5%. Embecta’s dividend payout ratio is presently 36.81%.

Institutional Trading of Embecta

Several institutional investors and hedge funds have recently made changes to their positions in EMBC. American Century Companies Inc. increased its holdings in shares of Embecta by 36.3% in the 2nd quarter. American Century Companies Inc. now owns 5,195,948 shares of the company’s stock valued at $50,349,000 after acquiring an additional 1,382,537 shares during the period. Jefferies Financial Group Inc. grew its position in shares of Embecta by 134.3% in the 2nd quarter. Jefferies Financial Group Inc. now owns 1,342,713 shares of the company’s stock worth $13,011,000 after buying an additional 769,713 shares during the last quarter. Ameriprise Financial Inc. raised its stake in shares of Embecta by 439.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 709,849 shares of the company’s stock worth $6,878,000 after acquiring an additional 578,174 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Embecta during the fourth quarter valued at approximately $5,178,000. Finally, Teacher Retirement System of Texas lifted its position in Embecta by 365.7% during the third quarter. Teacher Retirement System of Texas now owns 372,451 shares of the company’s stock valued at $5,255,000 after acquiring an additional 292,477 shares during the last quarter. 93.83% of the stock is currently owned by institutional investors.

About Embecta

(Get Free Report)

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.